MedPath

Feasibility Study to Actively Disseminate the Latin America and the Caribbean Code Against Cancer in Primary Healthcare Centers

Not Applicable
Not yet recruiting
Conditions
Cancer
Latin America and the Caribbean Code Against Cancer (LAC Code)
Registration Number
NCT06965608
Lead Sponsor
Hospital Israelita Albert Einstein
Brief Summary

Phase II non-randomized four-arm study (before/after pragmatic trial) that will test 2 different implementation strategies either combined or separately for the dissemination of the Latin America and the Caribbean Code Against Cancer within four different primary healthcare units in Aparecida de Goiânia.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
1200
Inclusion Criteria
  • Adults (≥18 years old)
  • Registered at a participating primary healthcare center (UBS) in Aparecida de Goiânia
  • Healthcare professionals with at least three months of employment at a participating UBS
  • Ability to provide informed consent
Exclusion Criteria
  • Prior diagnosis of any cancer or currently undergoing cancer treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Feasibility of the WhatsApp-Based InterventionUp to 2 weeks after WhatsApp intervention completion

Number of participants who report having read at least one WhatsApp message.

Acceptability of the WhatsApp-Based InterventionUp to 2 weeks after WhatsApp intervention completion

Mean acceptability score from participant survey (Likert scale 1-5) evaluating message usefulness and clarity.

Appropriateness of the WhatsApp-Based InterventionUp to 2 weeks after WhatsApp intervention completion

Proportion of participants who indicate willingness to receive similar messages in the future (Yes/No).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

HMAP - Hospital Municipal de Aparecida de Goiânia

🇧🇷

Aparecida de Goiania, GO, Brazil

© Copyright 2025. All Rights Reserved by MedPath